UPDATE 1-Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study
Yahoo! Finance
The companies said the trial, which has not been peer-reviewed, tested 10,000 participants aged 16 and older, and found that the booster shot had a favourable safety profile. The trial results come a day after the U.S. Food and Drug Administration authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans could choose a different shot from their original inoculation as a booster. Jefferies analyst Michael Yee said the trial results add to mount...
Continue Reading